Category: US Stock
Tesla delivered mixed Q2 results—production was resilient, but deliveries lagged. Profitability stabilized but margin...
Adagene is a clinical-stage biopharma firm developing antibody-based immunotherapies with proprietary platforms that optimize...
Abercrombie & Fitch continues to deliver strong topline growth and brand momentum, particularly via its Hollister platform...
Coya Therapeutics (Nasdaq: COYA) represents a high-risk, high-reward biotech play: minimal revenue, consistent losses, but...
Anebulo is a high-conviction, early-stage biotech play centered on a first-in-class pediatric cannabis intoxication antidote...
Connect Biopharma is transitioning from clinical-stage uncertainty to regulatory readiness and commercial preparation. With a...
Anebulo Pharmaceuticals is executing on a clear, high-impact strategy—developing an IV cannabis antidote for children—while...
CNTB upcoming rademikibart data updates and China approval pathway are critical triggers that could dramatically shift its...
Anebulo Pharmaceuticals is executing on a clear, high-impact strategy—developing an IV cannabis antidote for children—while...
PRA Group, Inc. (NASDAQ:PRAA), headquartered in Norfolk, Virginia, is a global leader in acquiring and collecting nonperforming...
Nano Dimension Ltd. (NASDAQ:NNDM), headquartered in Ness Ziona, Israel, is a leading provider of Additively Manufactured...
Globalstar, Inc. (NASDAQ:GSAT), headquartered in Covington, Louisiana, is a next-generation telecommunications provider offering...
Our Clients Reviews
Read what our clients have to say about their experience with EWNation.
